https://endpts.com/pfizer-has-run-41-trials-over-15-years-for-tanezumab-as-adcomm-nears-the-fda-remains-unimpressed/
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-1395
-
- There are more pages in this discussion • 3,002 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
22.0¢ |
Change
-0.010(4.35%) |
Mkt cap ! $76.95M |
Open | High | Low | Value | Volume |
23.5¢ | 23.5¢ | 21.5¢ | $258.8K | 1.172M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10139 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 6077 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 44000 | 0.220 |
5 | 49416 | 0.215 |
7 | 129266 | 0.210 |
4 | 104982 | 0.205 |
6 | 103000 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 1800 | 1 |
0.220 | 12307 | 1 |
0.225 | 9785 | 1 |
0.230 | 6077 | 1 |
0.235 | 20000 | 1 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online